News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

Tablets of abiraterone acetate, a drug discovered and developed at the ICR
New computer prediction tool can forecast how cancer will resist drugs before they are given to patients

23/08/18

Sophisticated new computer software can be used to predict how cancers may respond to a new drug before it has ever been given to patients.
Silver drug packets
Drug combination gives ‘exciting’ results in ovarian and lung cancer in early trial

22/08/18

Combining a new targeted cancer drug with chemotherapy has shown promise in an early clinical trial, in patients with ovarian or lung cancer for whom all other treatments had failed.
Breast epithelial cells under ER stress (Chris Bakal, 2014)
Breast cancer vulnerability could point way to new target treatments

20/08/18

Researchers have identified a vulnerability in some breast cancer cells of a certain type – called triple negative breast cancer – that could be exploited by future targeted drugs.
Computational model of brain
Tumour 'diaries' track cancers' evolutionary history and predict the future

15/08/18

Scientists have developed a complex mathematical model that uses a snapshot of tumours’ genetic code to reach back in time, revealing its evolutionary history.
Team Meeting in Sutton
Discovery Club members hear about how philanthropy is making a difference to people with cancer

14/08/18

Members of the ICR’s Discovery Club, our high-level giving club of visionary supporters, learned about the difference that philanthropy is making to people with cancer at an event in the impressive surroundings of Two Temple Place, in Central London.
Prostate Cancer Rosetta Stone (Mateus Crespo/Prof Johann de Bono, the ICR)
New prostate cancer blood test detects early treatment failure

11/08/18

A new prostate cancer blood test can detect early signs that cancer is evolving to become resistant to treatment, a new study has found.
Chronic myeloid leukaemia cells, image used form Wellcome Image Library
Increased risk of myeloid blood cancers in relatives of patients

07/08/18

​The largest ever study of its type is the first to definitively show an increased risk of blood cancers in relatives of patients.
Super-resolution MRI
New ‘super-resolution’ MRI could help plan radiotherapy treatment for lung cancer

01/08/18

Researchers have developed a new technique to create high-quality 3D movies of tissues in the body as they move, which could help doctors plan radiotherapy treatment for cancers including lung tumours.
dna-sequence
Scientists uncover DNA ‘shield’ with crucial roles in normal cell division, the immune system and cancer

18/07/18

Scientists have made a major discovery about how cells repair broken strands of DNA that could have huge implications for the treatment of cancer.
ICR Logo
ICR part of major MedTech commercialisation programme

17/07/18

The ICR is taking part in a major new initiative to drive forward world-class university commercialisation across the country, and encourage collaboration between higher education institutions.
Johann de Bono appearing on BBC Panorama_BBC, 2014
Tiny changes in prostate cancer blood test could spot early warning signs of treatment not working

16/07/18

A test that can detect trace levels of tumour cells in the blood could help spot early signs of treatment not working for men with advanced prostate cancer.
ICR Enterprise Breakfast event
ICR holds first networking event for scientists and commercial partners

13/07/18

The ICR’s Enterprise Unit has hosted our first ever event for our scientists to meet with possible future partners from the commercial sector.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.